Efficacy and safety of bevacizumab in neoadjuvant and concurrent chemoradiotherapy for refractory cervical cancer patients. Biomol Biomed [Internet]. 2024 May 16 [cited 2024 Jun. 30];. Available from: https://bjbms.org/ojs/index.php/bjbms/article/view/10528